Drugs

News and Updates about the regulations in Drugs and Pharma

Merck’s Phase 3 Study Reveals Successful Outcomes for Subcutaneous Pembrolizumab with Berahyaluronidase Alfa

Merck, recognized as MSD outside the United States and Canada, has announced encouraging topline outcomes from the pivotal phase 3 MK-3475A-D77 study. This investigation is analyzing whether the subcutaneous delivery of pembrolizumab—a renowned anti-PD-1 therapy by Merck, commercially known as […]

Merck’s Phase 3 Study Reveals Successful Outcomes for Subcutaneous Pembrolizumab with Berahyaluronidase Alfa Read More »

Pfizer’s Hympavzi Secures EU Authorization for Treating Severe Hemophilia A and B in Adolescents and Adults Without Inhibitors

Pfizer Inc. has revealed that the European Commission (EC) has authorized the market release of Hympavzi (marstacimab) for the routine prevention of bleeding episodes in individuals aged 12 and older, who weigh at least 35 kg, with severe hemophilia A

Pfizer’s Hympavzi Secures EU Authorization for Treating Severe Hemophilia A and B in Adolescents and Adults Without Inhibitors Read More »

Pharmexcil and Sberbank Explore Rupee-Ruble Payment Solutions to Enhance Indo-Russian Pharmaceutical Trade

In an important step to strengthen economic ties between India and Russia, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) and Russia’s largest bank, Sberbank, are in discussions to establish payment methods in Rupee-Ruble bilateral trade. These discussions aim to

Pharmexcil and Sberbank Explore Rupee-Ruble Payment Solutions to Enhance Indo-Russian Pharmaceutical Trade Read More »

Research from Ayush-ICMR Centers Set to Create National Reports for International Promotion of Ayush Remedies: Dr. Kotecha

The Indian Ayush Ministry’s partnerships with prestigious institutions such as the Indian Council of Medical Research (ICMR) aim to bolster the scientific grounds of Ayush treatments and facilitate their global recognition. Each initiative under these collaborations is crafted to enhance

Research from Ayush-ICMR Centers Set to Create National Reports for International Promotion of Ayush Remedies: Dr. Kotecha Read More »

Department of Pharmaceuticals Denies Abbott’s Appeal Against BP Drug Metoprolol Pricing

The Pharmaceuticals Department (DoP) has turned down Abbott Healthcare’s appeal against the pricing cap set by the National Pharmaceutical Pricing Authority (NPPA) for high blood pressure medication metoprolol in its modified release tablet form. This decision follows multiple denials by

Department of Pharmaceuticals Denies Abbott’s Appeal Against BP Drug Metoprolol Pricing Read More »

Karnataka Government to Establish Three Major Global Innovation Hubs in Bengaluru, Mysuru, and Belagavi

The Karnataka government is making significant strides to enhance its information technology and biotechnology sectors by leveraging the region’s workforce and infrastructure assets. To drive this vision forward, three dedicated global innovation hubs will be developed in Bengaluru, Mysuru, and

Karnataka Government to Establish Three Major Global Innovation Hubs in Bengaluru, Mysuru, and Belagavi Read More »

Industry Expert Highlights Importance of Enhanced Risk Management for Safety and Sustainability in Pharma Sector

The pharmaceutical industry must prioritize enhancing risk management to bolster safety and sustainability, asserts Kim Carlson Altom, Global Operations Risk Management Practice Director at dss+. She emphasizes the critical role of leadership in fostering a safety-conscious organizational culture. “Risk management

Industry Expert Highlights Importance of Enhanced Risk Management for Safety and Sustainability in Pharma Sector Read More »

Granules India Enlists Ovais Sarmad as Advisor for Sustainability and Climate Strategy Guidance

Granules India has engaged Ovais Sarmad as an Advisor to lend his expertise in sustainability, climate policy, and environmental endeavors, aiding the company in its ongoing pursuit of integrating sustainable practices throughout its business operations. With over three decades of

Granules India Enlists Ovais Sarmad as Advisor for Sustainability and Climate Strategy Guidance Read More »

Sova Health unveils Sova X, a tailored gut health innovation leveraging individual microbiomes

The innovative company Sova Health has introduced Asia’s inaugural personalized gut health product, Sova X, designed to work with the distinctive microbiome of each person. While probiotics have gained traction for enhancing gut health, their effectiveness varies among individuals. This

Sova Health unveils Sova X, a tailored gut health innovation leveraging individual microbiomes Read More »

Sightsavers India and AbbVie India Hold 4th State-Level Meeting on Glaucoma Visual Impairment Prevention

In their ongoing joint effort, Sightsavers India, together with AbbVie India, organized the fourth state-level meeting focused on the ‘Prevention of Visual Impairment Caused by Glaucoma.’ Glaucoma is a major contributor to blindness globally, requiring early diagnosis and swift intervention

Sightsavers India and AbbVie India Hold 4th State-Level Meeting on Glaucoma Visual Impairment Prevention Read More »